Reducing Clinical Trial Burdens Brings Greater Participant Diversity – PhRMA

Industry principles for enhancing diversity in clinical trials call for use of digital data collection tools and flexible scheduling of study site visits to reduce barriers to enrollment, as well as greater involvement of under-represented communities in the trial design planning process and recruitment of investigators with diverse ethnic and racial backrounds.

People with joined hands as a team
PhRMA and FDA offer similar strategies for improving clinical trial diversity. • Source: Shutterstock

More from Clinical Trials

More from R&D